Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages

Fig. 3

Breadth of CTA/SALL4-specific T cell response. The number of recognized individual CTA & SALL4 is shown for HCC patients according to the stage (25 subjects in 0/A stage and 33 subjects in B/C stage) (A) and the tumour volume (25 subjects with <15cm3 and 33 subjects with >15cm3) (B). Each dot represents one patient. Values were compared by Mann-Whitney U-test

Back to article page